Founded in 2017, Paris-headquartered health tech startup VirtualiSurg has launched its Singapore office, marking its international reach with offices in France, Brazil, Canada, Japan and Singapore, with a strong network of medical experts and partners globally.

The new Singapore office marks VirtualiSurg’s commitment to bringing continued and tailored on-ground support to key markets globally, especially in recognition of Singapore’s continued investment in environments for artificial intelligence and Extended Reality (XR) systems, as well as similar values upheld by the innovative Asia market regionally.

The latest report from InsightAce Analytic (2023) predicts that the global metaverse market focused on the health and healthcare industry will be worth $71.6 billion by 2030.

Representing the learning paradigm of the future, VirtualiSurg sees its role at the forefront of the  health tech innovation, creating high-fidelity simulations in response to permanent training needs, for surgical training, medical technologies and all other specialised professions that require technical dexterity and/or artisanship. Paving way for the next generation to benefit all of humanity, VirtualiSurg has a purpose to improve patient outcomes on a global scale, by empowering healthcare professionals at scale, with the confidence to deliver quality of care, ability and decision making skills. 

Its patented technology span a range of surgical and artisan procedures in realistic metaverse environments, offering a range of Extended Reality (XR) simulations that enable users to learn, perform and master procedures efficiently. 

VirtualiSurg’s current developments span globally renowned medtech giants spanning USA, Germany and Japan, including Medtronic, Johnson & Johnson and Dräger.